Obermatt
See Similar Stocks →

Oncolytics Biotech

NAQ:ONCY · CA6823108759
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings42
Price/Book85
Dividend Yield—
Revenue Growth—
Profit Growth91
Capital Growth1
TSR 52w78
Leverage8
Liquidity97
Refinancing31
Combined—
Analyst Opinions9
Pro Holdings5
Opinion Changes50
Market Pulse27

Profile

CountryCanada
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Founded1998
Employees38
Websiteoncolyticsbiotech.com
ISINCA6823108759
Last UpdateApr 2, 2026
Index & Theme
ImmunologyOncologyBiotechnologyHealth CareMedicalTherapeuticsWellness

Description

Oncolytics Biotech Inc. operates as a clinical-stage biopharmaceutical company. The company is developing pelareorep, a safe and well-tolerated intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and…

Similar Stocks

The companies this stock is ranked against.

Compare Oncolytics Biotech with its peers
Celcuity
NAQ:CELC
96
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Actuate Therapeutics
NMQ:ACTU
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Olema Pharmaceuticals
NSQ:OLMA
28
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Oric Pharmaceuticals
NSQ:ORIC
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Acrivon Therapeutics
NMQ:ACRV
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Nuvectis Pharma
NAQ:NVCT
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →